Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 15:8:657993.
doi: 10.3389/fmed.2021.657993. eCollection 2021.

Delayed Re-epithelialization After Epithelium-Off Crosslinking: Predictors and Impact on Keratoconus Progression

Affiliations

Delayed Re-epithelialization After Epithelium-Off Crosslinking: Predictors and Impact on Keratoconus Progression

Chiara Bonzano et al. Front Med (Lausanne). .

Abstract

Purpose: To investigate the demographic and corneal factors associated with the occurrence of delayed reepithelialization (DRE) after epithelium-off crosslinking (epi-off CXL). Design:Retrospective case series. Methods:A chart review was performed to identify patients treated with epi-off CXL. DRE was defined as a corneal epithelial defect detected by fluorescein staining that persisted for more than 10 days. Slit-lamp examination, anterior segment optical coherence tomography, corneal topography, and corneal in vivo confocal microscopy (IVCM) were always performed preoperatively and at each follow-up visit (1, 3, 6, 12 months). A generalized estimating equation was used to assess the baseline factors associated with DRE. Results:Data from 153 eyes were analyzed. The mean age of patients was 24.9 ± 8.5 years, and 47 (30.7%) were women. The average reepithelization time was 4.7 ± 1.8 days. Six eyes (3.9%) experienced DRE. In the multivariate model, both the age of the patient (OR = 1.30; p = 0.02) and the corneal steepest meridian (OR = 0.44, p = 0.047) were associated with DRE. Baseline nerve count was also associated with DRE (0.87, p = 0.03). Male gender was associated with a slower early nerve regrowth (1-6 months) (p = 0.048), but not with the occurrence of DRE (p = 0.27). Preoperative central corneal thickness was not related to DRE (p = 0.16). DRE was not associated with keratoconus progression after epi-off CXL (p = 0.520). Conclusions:The association between DRE and age may reflect the age-related decrease in the corneal healing response. Also, low baseline corneal nerve count is associated with DRE. Gender seems to affect reinnervation measured by IVCM but not the reepithelization time. DRE does not seem to affect the efficacy of epi-off CXL.

Keywords: accelerated corneal crosslinking; bandage contact lens; delayed re-epithelialization; epithelium-off crosslinking; keratoconus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Delayed re-epithelialization after the epithelium-off CXL (epi-off CXL) imaged with a multimodal approach. White arrows point at the edges of the epithelial fronts and green arrows points to the demarcation line, and the red arrow points to the bandage lens. OCT scan over the disepithelized area at baseline (A). Photograph obtained at baseline with diffuse white light (B) and with fluorescein staining (green) photograph obtained under cobalt-blue light illumination (C) imaged at baseline. (D,E) were acquired at the end of treatment at 3 and 10 days respectively. They show a residual corneal epithelial disepithelialization. OCT scan over the re-epithelialization area at day 15 (F). Photograph obtained at day 15 with diffuse white light (G) and with fluorescein staining (green) photograph obtained under cobalt-blue light illumination (H).

References

    1. Sharif R, Bak-Nielsen S, Hjortdal J, Karamichos D. Pathogenesis of keratoconus: the intriguing therapeutic potential of prolactin-inducible protein. Prog Retin Eye Res. (2018) 67:150–67. 10.1016/j.preteyeres.2018.05.002 - DOI - PMC - PubMed
    1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. (1998) 42:297–319. 10.1016/S0039-6257(97)00119-7 - DOI - PubMed
    1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. (2003) 135:620–7. 10.1016/S0002-9394(02)02220-1 - DOI - PubMed
    1. Mazzotta C, Baiocchi S, Bagaglia SA, Fruschelli M, Meduri A, Rechichi M. Accelerated 15 mW pulsed-light crosslinking to treat progressive keratoconus: two-year clinical results. J Cataract Refract Surg. (2017) 43:1081–8. 10.1016/j.jcrs.2017.05.030 - DOI - PubMed
    1. Wittig-Silva C, Chan E, Islam FMA, Wu T, Whiting M, Snibson GR, et al. . Randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus. Ophthalmology. (2014) 121:812–21. 10.1016/j.ophtha.2013.10.028 - DOI - PubMed

LinkOut - more resources